Roots Analysis has announced the addition of “Cell Therapy Manufacturing Market (2nd Edition), 2018-2030” report to its list of offerings.
Natasha Thakur, the principal analyst, stated, &ldq...
For kidneys, Roots Analysis, a medical-technology consultancy, reckons that should be possible in about six years’ time. Livers, which have a natural tendency to regenerate anyway, should also arrive reasonably soon. Hearts, with their complex inte..
The market in novel alternatives to needle injections is forecasted to grow rapidly, reaching in excess of 480 million units by 2030..
Roots Analysis predicts the gene therapy market as a whole to reach ~$11 bln by 2025..
Roots Analysis, a market research and consulting firm for the pharmaceutical industry, says that growth will add to the estimated “current global contract pharmaceutical installed manufacturing capacity of 125 million liters [30.4 million U.S. gall..
With the wearable device market expected to provide a smart and straightforward drug delivery experience to patient populations worldwide..
There are few companies with the capability to commercially manufacture viral vectors; most of the 24 firms identified by Roots Analysis in a 2016 report are CDMOs...
Roots Analysis estimates there are over 500 gene therapy candidates in clinical development, with approximately 1,700 clinical studies underway around the world...